Impaired Myocardial Flow Reserve on Rubidium-82 Positron Emission Tomography Imaging Predicts Adverse Outcomes in Patients Assessed for Myocardial Ischemia
María Cecilia Ziadi(University of Ottawa), Rob Beanlands(University of Ottawa), Robert A. deKemp(University of Ottawa), Terrence D. Ruddy(University of Ottawa), Jennifer M. Renaud(University of Ottawa), Rebecca Tee(University of Ottawa), Kathryn Williams(Boston Children's Hospital), Ann Guo(University of Ottawa), Niroshi Sarveswaran(University of Ottawa), Benjamin J.W. Chow(Tufts Medical Center)
Cited by 602
Related Papers
Anatomic Versus Physiologic Assessment of Coronary Artery Disease
|Journal of the American College of Cardiology|2013|563
The Use of <sup>18</sup>F-FDG PET in the Diagnosis of Cardiac Sarcoidosis: A Systematic Review and Metaanalysis Including the Ontario Experience
|Journal of Nuclear Medicine|2012|512
F-18-Fluorodeoxyglucose Positron Emission Tomography Imaging-Assisted Management of Patients With Severe Left Ventricular Dysfunction and Suspected Coronary Disease
|Journal of the American College of Cardiology|2007|476
Prognostic Value of Noninvasive Cardiovascular Testing in Patients With Stable Chest Pain
|Circulation|2017|450
Does quantification of myocardial flow reserve using rubidium-82 positron emission tomography facilitate detection of multivessel coronary artery disease?
|Journal of Nuclear Cardiology|2012|303